The primary objective of the trial is to evaluate the safety of apraglutide in adult subjects with SBS-IF and CIC.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Number of Participants Who Experienced a Treatment-Emergent Adverse Event (TEAE)
Timeframe: Day 1 up to approximately 55 weeks
Absolute Change in Absorption of Energy Over Metabolic Balance (MB) Periods From Baseline at Week 48
Timeframe: Baseline and Week 48